University of Alabama at Birmingham, School of Medicine

Birmingham, Alabama 70121

5 studies enrolling now · 26 studies all time

What they study most

B-cell Non-Hodgkin Lymphoma, Candidemia, Candidiasis, Invasive, Cardiovascular Disease, Cervical Cancer, Chronic Kidney Disease, Cushing's Syndrome, Death, Diabetes, Diffuse Large B-cell Lymphoma, End-Stage Kidney Disease, Healthy

Studies at this site

• Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates — Recruiting now
• A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo — Recruiting now
• BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies — Recruiting now
• A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose — Recruiting now
• A Study to Learn About How a New Pneumococcal Vaccine Works in Infants. — Recruiting now
• Open-label Study of ELA026 in Participants With Secondary Hemophagocytic Lymphohistiocytosis (sHLH) — Recruiting now
• The Arteriovenous Vascular (AV) ACCESS Trial — Running, not enrolling
• Study to Evaluate the Safety, Tolerability, and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy Children — Completed
• Safety Study of a Vaccine to Help Protect Against Lyme Disease in Healthy Children — Completed
• Study of Tirabrutinib (ONO-4059) in Patients With Primary Central Nervous System Lymphoma (PROSPECT Study) — Running, not enrolling
• RaPiDS- A Phase 2 Study of Anti-PD-1 Independently or in Combination With Anti-CTLA-4 in Second-Line Cervical Cancer — Stopped early
• A Study to Learn About the Study Medicine (PF-06823859) in Adults With Active CLE or SLE With Skin Symptoms. — Stopped early
• A Phase 3, Randomized, Double-blind Study for Patients With Invasive Candidiasis Treated With IV Echinocandin Followed by Either Oral Ibrexafungerp or Oral Fluconazole — Stopped early
• ICoN-1 Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101, Clofazimine Inhalation Suspension — Stopped early
• An Efficacy and Safety Study of APX001 in Non-Neutropenic Patients With Candidemia — Completed
• Trial of Mosunetuzumab (BTCT4465A) as Consolidation Therapy in Participants With Diffuse Large B-Cell Lymphoma Following First-Line Immunochemotherapy and as Monotherapy or in Combination With Polatuzumab Vedotin in Elderly/Unfit Participants With Previously Untreated Diffuse Large B-Cell Lymphoma — Completed
• A Study to Learn About the Safety and Immune Activity of RSVpreF in Children 2 to <18 Years of Age — Completed
• A Study to Evaluate the Safety and Efficacy of Mosunetuzumab (BTCT4465A) in Combination With Polatuzumab Vedotin in B-Cell Non-Hodgkin Lymphoma — Running, not enrolling
• Safety and Effectiveness of Nabiximols Oromucosal Spray as Add-on Therapy in Participants With Spasticity Due to Multiple Sclerosis — Stopped early
• A Study to Investigate the Safety and Efficacy of PA21 (Velphoro®) and Calcium Acetate (Phoslyra®) in Paediatric and Adolescent Chronic Kidney Disease (CKD) Patients With Hyperphosphataemia — Stopped early
• Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT) — Completed
• Efficacy and Safety Study of ARC-4558 for Management of Pain Associated With Painful Diabetic Neuropathy — Completed
• An Extension Study of CORLUX in the Treatment of Endogenous Cushing's Syndrome — Completed
• Study of Metanx® in Subjects With Type 2 Diabetic Peripheral Neuropathy (DPN) — Completed
• A Study of the Efficacy and Safety of CORLUX in the Treatment of Endogenous Cushing's Syndrome — Completed
• Phase 1 Study of BHT-3021 in Subjects With Type 1 Diabetes Mellitus — Completed